Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-25 @ 3:12 AM
Ignite Modification Date: 2025-12-26 @ 1:51 AM
NCT ID: NCT00408005
Term: Neutrophil count decreased
Organ System: Investigations
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCv4
Notes: None
Study: NCT00408005
Study Brief: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 98 97 1563 View
EG001 0 0 368 View
EG002 710 276 372 View
EG003 189 89 147 View
EG004 1010 331 451 View
EG005 277 116 219 View
EG006 8 8 285 View
EG007 1 1 80 View
EG008 208 100 143 View
EG009 76 35 62 View